Yes, it's true. Gateway Analytical has one of the fastest turnaround times in the industry.

Better results. Faster. As soon as your sample comes through the door, we spring into action to properly log it, store it, and notify the individual scientists that will be diligently working on your project. Then it's off to specialized sample preparation and analytical probing by our fleet of cutting edge instruments. You'll have data, interpretation, and solutions in no time.

Gateway Analytical has carefully assembled a diverse team of curious experts. When the other guys run away from difficult problems or second guess their approach, our scientists move in to take a closer look with a forensic-based framework. Our process is focused on outcomes and driven by experts that have seen it all. You bring challenges. We deliver creative solutions.

We're not just another analytical lab. Why not? We spent years building a leading position in the highly-regulated pharmaceutical industry. That means our facilities are FDA-inspected, cGMP certified, and maintain ISO 9001 (quality management) and ISO 17025 (testing and calibration) standards. Simply put, there's a high bar for quality in all our work that others just can't match.

We've ditched one-size-fits-all customer service for a more personal, collaborative approach.

When you need us, call us. We're always here to answer your questions. As our growing list of returning customers has learned, you'll get to know the individual scientists working with your team to deliver results. They're real people. Our innovative real-time collaboration technology even allows us to demonstrate results and provide updates -- live from the lab.

Breadcrumb

The active pharmaceutical ingredient (API) size distribution within the final formulation of a drug product is critical as it relates to bioavailability, rates of absorption, and stability of that drug product. Due to the potential significant impact related to the active pharmaceutical ingredient (API) size and shape, gaining an understanding of this information is of great importance to regulatory agencies, specifically when it relates to in vitro bioequivalence studies.